Patents by Inventor Dragos Alevizache

Dragos Alevizache has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20190008761
    Abstract: This application discloses effervescent spheroidal shaped tablets for dietary supplements, nutraceuticals, or functional foods, and methods for making and producing the tablets.
    Type: Application
    Filed: July 7, 2017
    Publication date: January 10, 2019
    Inventor: DRAGOS ALEVIZACHE
  • Patent number: 9993447
    Abstract: Formulations of hydrosoluble stable organic salts including, but not limited to, agmatine orotate, agmatine di-hydrochloride, agmatine phosphate, buffered agmatine or spray dried buffered agmatine base, whether alone or in combination with one another, are provided, as well as methods for making same. These agmatine salts may have improved solubility in aqueous and organic media and may have increased absorbability and/or tissue bioavailability in humans and animals when compared to agmatine sulfate. These formulations may be administered as a means for improving athletic performance, training resistance and/or cognitive function. These formulations also may increase cellular uptake of agmatine in an animal or human.
    Type: Grant
    Filed: September 13, 2016
    Date of Patent: June 12, 2018
    Assignee: JW Nutritional, LLC
    Inventors: Dragos Alevizache, Jesse Windrix
  • Publication number: 20170071883
    Abstract: Formulations of hydrosoluble stable organic salts including, but not limited to, agmatine orotate, agmatine di-hydrochloride, agmatine phosphate, buffered agmatine or spray dried buffered agmatine base, whether alone or in combination with one another, are provided, as well as methods for making same. These agmatine salts may have improved solubility in aqueous and organic media and may have increased absorbability and/or tissue bioavailability in humans and animals when compared to agmatine sulfate. These formulations may be administered as a means for improving athletic performance, training resistance and/or cognitive function. These formulations also may increase cellular uptake of agmatine in an animal or human.
    Type: Application
    Filed: September 13, 2016
    Publication date: March 16, 2017
    Inventors: Dragos Alevizache, Jesse Windrix